Chromatin remodelling drives immune cell–fibroblast communication in heart failure
Open accessAbstract
Chronic inflammation and tissue fibrosis are common responses that worsen organ function, yet the molecular mechanisms governing their cross-talk are poorly understood. In diseased organs, stress-induced gene expression changes fuel maladaptive cell state transitions1 and pathological interaction between cellular compartments. Although chronic fibroblast activation worsens dysfunction in the lungs, liver, kidneys and heart, and exacerbates many cancers2, the stress-sensing mechanisms initiating transcriptional activation of fibroblasts are poorly understood. Here we show that conditional deletion of the transcriptional co-activator Brd4 in infiltrating Cx3cr1+ macrophages ameliorates heart failure in mice and significantly reduces fibroblast activation. Analysis of single-cell chromatin accessibility and BRD4 occupancy in vivo in Cx3cr1+ cells identified a large enhancer proximal to interleukin-1β (IL-1β, encoded by Il1b), and a series of CRISPR-based deletions revealed the precise stress-dependent regulatory element that controls Il1b expression. Secreted IL-1β activated a fibroblast RELA-dependent (also known as p65) enhancer near the transcription factor MEOX1, resulting in a profibrotic response in human cardiac fibroblasts. In vivo, antibody-mediated IL-1β neutralization improved cardiac function and tissue fibrosis in heart failure. Systemic IL-1β inhibition or targeted Il1b deletion in Cx3cr1+ cells prevented stress-induced Meox1 expression and fibroblast activation. The elucidation of BRD4-dependent cross-talk between a specific immune cell subset and fibroblasts through IL-1β reveals how inflammation drives profibrotic cell states and supports strategies that modulate this process in heart disease and other chronic inflammatory disorders featuring tissue remodelling. Conditional deletion of the transcriptional co-activator Brd4 in infiltrating Cx3cr1+ mouse macrophages ameliorates heart failure and substantially reduces fibroblast activation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
42 of 45 cited sources checked · 28 supported · 0 flagged · accuracy not yet measured
- Premisecitation
JQ1-associated transcriptional changes in cardiomyocytes are modest compared with other cardiac cell populations.
“Given our observation that transcriptional changes associated with JQ1 in the cardiomyocyte (CM) compartment are modest compared to other cardiac cell populations4,11”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- cites [11] Padmanabhan, A. et al. BRD4 (bromodomain-containing protein 4) interacts with GATA4 (GATA binding protein 4) to govern mitochondrial homeostasis in adult cardiomyocytes. Circulation 142, 2338–2355 (2020). source
The Results section reports that JQ1-treated sham-operated mouse hearts showed no dramatic transcriptional changes. The Discussion suggests that JQ1’s dominant targets in heart failure may be non-cardiomyocytes, but the paper does not directly compare JQ1-associated transcriptional changes in cardiomyocytes with those in other cardiac cell populations. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Findingown data
Flow cytometry at day 7 after TAC showed no significant change in infiltrated immune cell, monocyte or macrophage numbers after JQ1.
“Flow cytometry analyses of cardiac tissue at day 7 post-TAC, a time point associated with immune cell expansion23,24, revealed no significant changes in the number of infiltrated immune cells, monocytes, or macrophages following JQ1 (Extended Data Fig. 1H,I).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [23] Patel, B. et al. CCR2+ monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. JACC Basic Transl. Sci. 3, 230–244 (2018). source
- cites [24] Revelo, X. S. et al. Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis. Circ. Res. 129, 1086–1101 (2021). source
- Findingown data
Myeloid clusters 1 and 5 highly expressed Ccr2, a marker of monocyte-derived macrophages that enter from the circulation.
“Clusters 1 and 5 had high expression of Ccr2, a marker of monocyte-derived macrophages that infiltrate from the circulation17-19 (Fig. 1J and Extended Data Fig. 1C-E).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [17] Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047 (2007). source
The Results section on chemokine-mediated recruitment (page unavailable) reports that circulating Ly-6Chi monocytes selectively express CCR2 and that their recruitment into infarcted myocardium depends on it. The paper distinguishes these monocytes from macrophages, however, and the cited passages do not establish CCR2 as a marker specifically of monocyte-derived macrophages. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [18] Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104 (2014). source
- cites [19] Bajpai, G. et al. Tissue resident CCR2− and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ. Res. 124, 263–278 (2019). source
- Premisecitation
BRD4 has specific importance in aspects of heart failure pathogenesis.
“We previously showed the specific importance of BRD4 in aspects of heart failure pathogenesis4,25.”
Quote in the paperSubstantial claim2 of 2 sources checked - Findingown data
Among cardiac cell clusters, fibroblasts showed the strongest enrichment for genes whose expression tracked cardiac function.
“As expected4, fibroblasts had the highest enrichment of genes whose expression significantly correlated with cardiac function (Fig. 1E).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
The ‘Chromatin state and cardiac function’ section reports correlations between cardiac function and fibroblast enhancer accessibility, not gene expression. The ‘Transcriptional plasticity of fibroblasts’ section describes fibroblast transcriptomic changes, but our copy does not show that fibroblasts had the highest enrichment of genes whose expression significantly correlated with cardiac function. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Findingown data
In mice with pressure-overload heart failure, BET inhibition with JQ1 strongly protected left ventricular ejection fraction.
“BET inhibition exerted a strong protective effect on left ventricular ejection fraction (Fig. 1B)4,6-10.”
Quote in the paperSubstantial claim6 of 6 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- cites [6] Anand, P. et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 154, 569–582 (2013). source
- cites [7] Spiltoir, J. I. et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 63, 175–179 (2013). source
The Results report that JQ1 rescued pressure-overload-induced left ventricular systolic dysfunction in mice subjected to transverse aortic constriction, as assessed by echocardiography. The available Results passage does not identify ejection fraction as the measure or quantify the strength of its protection, so those specifics are not verified. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [8] Duan, Q. et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aah5084 (2017). source
- cites [9] Antolic, A. et al. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy. JCI Insight 5, e138687 (2020). source
The results report that JQ1 improved left-ventricular systolic function in PLN R9C mice with genetic dilated cardiomyopathy, as measured by fractional shortening. The Methods and results do not report ejection fraction or a pressure-overload heart-failure experiment in these mice; the Discussion mentions aortic banding only in connection with prior studies. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [10] Auguste, G. et al. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice. J. Clin. Invest. 130, 4740–4758 (2020). source
The 'Effects of JQ1 on cardiac function' section reports improved left ventricular function after JQ1 treatment, but the mice had myocyte-specific lamin A/C deficiency, not pressure-overload heart failure. It reports improved fractional shortening (LVFS), not a measured protective effect on ejection fraction. The paper mentions beneficial effects in pressure-overload models only when discussing previous studies; page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Findingown data
Cx3cr1 was particularly enriched in myeloid cluster 1, together with proinflammatory genes such as Il1b.
“Cx3cr1, which marks both monocyte-derived and resident macrophages20-22, was particularly enriched in cluster 1, together with proinflammatory genes such as Il1b (Fig. 1J).”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [20] Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013). source
The Introduction describes CX3CR1 expression in monocytes, and Results > Dual origins of resident macrophages identifies CX3CR1-positive resident macrophages (no page number provided). These passages support the marker’s relevance to both populations, but do not establish that it marks monocyte-derived macrophages specifically. The cluster 1 and Il1b findings are attributed to the citing paper’s Figure 1J, not to this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [21] Pinto, A. R. et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS ONE 7, e36814 (2012). source
The Results section on the cTM gene-expression signature identifies Cx3cr1-GFP-positive cardiac tissue macrophages and says the GFP-positive splenic population includes monocytes and macrophages. It does not establish that Cx3cr1 marks both monocyte-derived and resident macrophages as distinct origins. The cluster 1 enrichment is attributed to the citing paper’s Fig. 1J, not to this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [22] Lee, M., Lee, Y., Song, J., Lee, J. & Chang, S.-Y. Tissue-specific role of CX3CR1 expressing immune cells and their relationships with human disease. Immune Netw. 18, e5 (2018). source
- Findingcitation
The Il1b distal region was among the genomic regions most enriched for p65/RELA binding in BMDMs.
“The Il1b distal region was among the most enriched genomic regions in p65/RELA binding (Fig. 4J and Extended Data Fig. 6B).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [29] Link, V. M. et al. Analysis of genetically diverse macrophages reveals local and domain-wide mechanisms that control transcription factor binding and function. Cell 173, 1796–1809 (2018). source
The Results section on TF binding reports P65 ChIP-seq in BMDMs, but does not identify the Il1b distal region or rank its P65 binding against other genomic regions. Searches for Il1b, interleukin-1 beta, and the claimed enrichment found no passage addressing that comparison; page numbers were unavailable in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured
- Findingown data
Chromatin accessibility was reduced at the Postn and Meox1 loci in TAC-Brd4KO fibroblasts, including regulatory elements previously shown to be essential for stress-induced activation of those genes.
“We found reductions in chromatin accessibility at the Postn and Meox1 loci in TAC-Brd4KO fibroblasts, including regulatory elements we previously showed were essential for stress-induced activation of those genes (Fig. 3Q, regions highlighted in red)4.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- Findingown data
H3K27Ac ChIP-seq in human iPSC-derived cardiac fibroblasts found that the strongly enriched region was the syntenic element of the mouse stress-dependent Meox1 Peak9/10 enhancer.
“Within the human MEOX1 locus, we found that the region associated with strong enrichment of H3K27Ac was the syntenic element of the mouse stress-dependent Meox1 Peak9/10 enhancer4 (Fig. 5D).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- Findingown data
A catalog of 748 large enhancers was assembled from scATAC-seq data from diseased TAC hearts.
“we assembled a catalog of 748 large enhancers28 using scATAC-seq data from diseased hearts (TAC) (Extended Data Fig. 6A).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [28] Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307–319 (2013). source
- Premisecitation
Pharmacological inhibition of BET proteins modulates a reversible transcriptional switch that governs fibroblast activation in chronic heart failure through the transcription factor MEOX1.
“We previously demonstrated that pharmacological inhibition of bromodomain and extra-terminal domain (BET) proteins, critical mediators of stress-activated chromatin signaling in various diseases3, modulates a reversible transcriptional switch that governs fibroblast activation in chronic heart failure through the transcription factor (TF) MEOX14.”
Quote in the paperSubstantial claim2 of 2 sources checked - Findingown data
RNA-seq and DE analysis among fibroblasts identified a small group of genes sensitive to TGFB and further increased by TGFB plus IL1B, including SERPINA9, EGR2, LRRC152 and MEOX1.
“RNA-seq and DE analysis among fibroblasts identified a small group of genes that were sensitive to TGFB stimulation and had increased expression when TGFB and IL1B were used in combination (Fig. 5B). These included genes such as SERPINA9, EGR2, LRRC152 and MEOX1, a critical transcriptional regulator of cardiac fibroblast activation.4.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- Premisecitation
Anti-inflammatory therapies targeting essential immune modulators are associated with serious adverse events such as a higher incidence of fatal infection and sepsis.
“they are also associated with serious adverse events such as a higher incidence of fatal infection and sepsis36,38.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [36] Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New Engl. J. Med. 377, 1119–1131 (2017). source
- cites [38] Rhee, A. J. & Lavine, K. J. New approaches to target inflammation in heart failure: harnessing insights from studies of immune cell diversity. Annu. Rev. Physiol. 82, 1–20 (2020). source
In “Targeting Monocytes and Macrophages in Heart Failure” (page unavailable), the review says immune-suppressing or immune-modulating therapies may increase the risk of opportunistic or life-threatening infections, citing CANTOS as an example. Our copy does not specify a higher incidence of fatal infection or sepsis, so those details are not supported. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
A parallel contemporaneous study using explanted human heart tissue from patients with cardiomyopathy or acute myocardial infarction independently identified IL1B-mediated macrophage-fibroblast communication as a regulator of pathologic fibroblast activation.
“a parallel contemporaneous study utilizing explanted human heart tissue from patients with cardiomyopathy or acute myocardial infarction independently identified IL1B-mediated macrophage-fibroblast communication as a regulator of pathologic fibroblast activation35.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [35] Amrute, J. M. et al. Targeting immune–fibroblast cell communication in heart failure. Nature https://doi.org/10.1038/s41586-024-08008-5 (2024). source
- Premisecitation
An exploratory analysis of a clinical trial evaluating systemic administration of an IL1B neutralizing antibody for ischemic cardiac disease identified a reduction in heart failure hospitalization and heart-failure related mortality.
“an exploratory analysis of a clinical trial evaluating systemic administration of an IL1B neutralizing antibody for the treatment of ischemic cardiac disease36 identified a reduction in heart failure hospitalization and heart-failure related mortality37.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [36] Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New Engl. J. Med. 377, 1119–1131 (2017). source
- cites [37] Everett, B. M. et al. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139, 1289–1299 (2019). source
- Premisecitation
MEOX1 is a critical regulator of the stress-activated fibroblast response.
“a critical regulator of the stress-activated fibroblast response4”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
- Findingown data
Brd4 deletion in Cx3cr1-positive cells also reduced fibrosis.
“Notably, Brd4 deletion in Cx3cr1-positive cells also reduced fibrosis”
- Also stated in: § BRD4 function in Cx3cr1+ cells during heart failure · plain
“Notably, Brd4 deletion in Cx3cr1-positive cells also reduced fibrosis (Extended Data Fig. 2C).”
Quote in the paperSubstantial claim - Also stated in: § BRD4 function in Cx3cr1+ cells during heart failure · plain
- Findingown data
Cx3cr1CreERT2;Brd4flox/flox mice showed improved cardiac function by echocardiography 30 days after TAC compared with littermate controls.
“When compared with littermate controls (Cx3cr1CreERT2 or Brd4flox/flox), Cx3cr1CreERT2;Brd4flox/flox mice demonstrated improved cardiac function by echocardiography 30 days after TAC (Fig. 1N).”
Quote in the paperSubstantial claim - Findingown data
Myeloid cells had the second-largest number of genes whose expression correlated with cardiac function.
“Myeloid cells had the next highest number of correlated genes, indicating a high degree of transcriptional plasticity in response to stress and BET inhibition (Fig. 1E).”
Quote in the paperSubstantial claim - Findingown data
Anti-correlated myeloid genes included cytokines such as Il1b, chemokines Ccl8 and Ccl12, chemokine receptor Cx3cr1, CD proteins and transcription factor Runx3.
“Among the anti-correlated genes were cytokines (Il1b), chemokines (Ccl8, Ccl12), chemokine receptors (Cx3cr1), cluster of differentiation (CD) proteins and the TF Runx3 (Fig. 1G).”
Quote in the paperNot a substantial claim - Findingown data
Brd4 deletion in resident macrophages did not significantly improve cardiac function.
“Brd4 deletion in resident macrophages did not lead to a significant improvement in cardiac function (Extended Data Fig. 2F)”
Quote in the paperSubstantial claim - Findingown data
GO analysis of genes driving cluster 4 (infiltrating monocytes) was enriched for pro-inflammatory terms including cellular response to LPS, positive regulation of inflammatory response and cytokine production.
“GO analysis of the genes driving cluster 4 (infiltrating monocytes) were enriched in terms related to the pro-inflammatory response, such as cellular response to lipopolysaccharide (LPS), positive regulation of inflammatory response and cytokine production (Fig. 2F).”
Quote in the paperSubstantial claim - Findingown data
In myeloid cells, the most enriched GO terms for genes downregulated by BET inhibition related to proinflammatory mechanisms such as cytokine and TNF production and macrophage activation.
“However, in myeloid cells the most enriched GO terms for genes significantly downregulated by BET inhibition were linked to proinflammatory mechanisms like regulation of cytokine and TNF production and macrophage activation (Fig. 1L).”
Quote in the paperSubstantial claim - Findingown data
DE analysis in the monocyte/macrophage population identified 13 genes, including Rgs1, Il1b, Cd52, Cd72 and Cx3cr1, that increased with TAC stress and decreased after Brd4 deletion in Cx3cr1-positive cells.
“We performed DE analysis in the monocyte/macrophage population between samples (Extended Data Fig. 2N), and identified 13 genes, including Rgs1, Il1b, Cd52, Cd72, and Cx3cr1, that were upregulated by TAC stress and decreased upon Brd4 deletion in Cx3cr1-positive cells (Fig. 2H).”
Quote in the paperSubstantial claim - Findingown data
In the merged analysis, cluster 1 displayed the highest expression of Postn and Meox1.
“displayed the highest expression of Postn and Meox1 (Extended Data Fig. 12D,E)”
Quote in the paperNot a substantial claim - Findingown data
Deletion of Brd4 in Cx3cr1-expressing cells caused an equally dramatic transcriptomic shift in fibroblasts, a population not genetically perturbed.
“but also an equally dramatic transcriptomic shift in fibroblasts, a population of cells that had not been genetically perturbed.”
Quote in the paperSubstantial claim - Findingown data
IL1B combined with TGFB triggered increased collagen contraction compared with TGFB alone.
“IL1B in combination with TGFB triggered increased collagen contraction, a functional hallmark of fibroblast activation, compared to TGFB alone (Extended Data Fig. 9E).”
Quote in the paperSubstantial claim - Findingown data
UMAP representation distinctly separated TAC Il1bflox/flox and TAC Il1b-KO fibroblasts.
“The UMAP representation distinctly separated Il1bflox/flox (TAC) and Cx3cr1CreERT2; l1bflox/flox (TAC Il1b-KO) fibroblasts”
Quote in the paperSubstantial claim - Findingown data
Single-cell RNA sequencing of non-cardiomyocytes from IgG- and anti-IL1B-treated TAC hearts captured 24,279 cells across 14 transcriptomic clusters that included myeloid, endothelial, and fibroblast cells.
“captured 24,279 cells in 14 transcriptomic clusters, encompassing myeloid, endothelial, and fibroblast cells (Extended Data Fig. 10B,C).”
Quote in the paperSubstantial claim - Findingown data
Il1b Peak5 and 6 enhancers cloned into a luciferase reporter showed additive coregulation by BRD4 and p65/RELA in controlling transcriptional activity.
“To test this, we separately cloned the Il1b Peak5 and 6 enhancers into a luciferase reporter and demonstrated additive coregulation by BRD4 and p65/RELA in controlling the transcriptional activity of these regions (Fig. 4N).”
Quote in the paperSubstantial claim - Findingown data
GO analysis of chromatin regions in cluster 4 showed enrichment for proinflammatory processes compared with resident macrophages in cluster 3.
“GO analysis of chromatin regions in cluster 4 showed enrichment for proinflammatory processes compared to resident macrophages (cluster 3). (Fig. 4G).”
Quote in the paperSubstantial claim - Findingown data
There were distinct transcriptional consequences in response to IL1B antibody neutralization versus Il1b genetic deletion.
“We also observed distinct transcriptional consequences in response to either the IL1B antibody neutralization or Il1b genetic deletion”
Quote in the paperNot a substantial claim - Findingown data
Among 7 fibroblast chromatin subclusters, gene scores suggested clusters 4 and 5 were enriched for Postn and Meox1 signals and other activated fibroblast markers.
“Amongst 7 fibroblast chromatin subclusters (Fig. 3J,K), gene scores (a measure of chromatin accessibility within and around the gene body) suggested that clusters 4 and 5 were enriched for signals from Postn and Meox1, as well as other markers of activated fibroblasts (Fig. 3L and Extended Data Fig. 4B,C).”
Quote in the paperSubstantial claim - Findingown data
In the merged analysis, cluster 1 had the greatest enrichment of gene programs linked to fibroblast activation and fibrosis.
“and the greatest enrichment of gene programs linked to fibroblast activation and fibrosis (Extended Data Fig. 12F).”
Quote in the paperSubstantial claim - Findingown data
Most genes downregulated in TAC-Brd4KO versus TAC in scRNA-seq were bound by BRD4 in Cx3cr1-expressing cells under TAC.
“Notably, most of the downregulated genes in TAC-Brd4KO versus TAC in the scRNA-seq data were bound by BRD4 in Cx3cr1-expressing cells in the TAC condition (Extended Data Fig. 6G,H).”
Quote in the paperSubstantial claim - Findingown data
Both IL1B neutralizing antibody treatment and monocyte-specific Il1b deletion similarly inhibited profibrotic gene transcription.
“both IL1B neutralizing antibody treatment and monocyte-specific Il1b deletion similarly inhibited profibrotic gene transcription”
Quote in the paperSubstantial claim - Findingown data
Single-cell chromatin accessibility and in vivo BRD4 occupancy analysis in Cx3cr1-positive cells identified a large enhancer proximal to Il1b.
“Analysis of single-cell chromatin accessibility and BRD4 occupancy in vivo in Cx3cr1-positive cells identified a large enhancer proximal to Interleukin-1 beta (Il1b)”
Quote in the paperSubstantial claim - Findingown data
TF motif analysis found REL, IKZF1 and RUNX2 as the top three most enriched motifs in cluster 4 versus cluster 3.
“TF motif analysis of these regions found REL, IKZF1, and RUNX2 at the top 3 most enriched motifs in cluster 4 versus cluster 3 (Fig. 4H).”
Quote in the paperSubstantial claim - Findingown data
Fibroblast cluster 1 showed depletion of fibroblasts from TAC Il1b-KO.
“demonstrated a depletion of fibroblasts from TAC Il1b-KO (Fig. 5R).”
Quote in the paperSubstantial claim - Findingown data
One of the most dynamic BRD4-bound distal elements under stress and after Brd4 deletion was proximal to Il1b.
“One of the most dynamic BRD4-bound distal elements in stress and upon genetic deletion of Brd4 was proximal to Il1b (Fig. 4I).”
Quote in the paperSubstantial claim - Findingown data
Secreted IL1B activated a fibroblast p65/RELA-dependent enhancer near MEOX1, producing a profibrotic response in human cardiac fibroblasts.
“Secreted IL1B activated a fibroblast p65/RELA-dependent enhancer near the transcription factor MEOX1, resulting in a profibrotic response in human cardiac fibroblasts.”
Quote in the paperSubstantial claim - Findingown data
Among the 15 most affected distal regions were DNA elements proximal to genes such as Il1b, Mreg, Cdh26, Cdh23, Cd83, Ccrl2 and Egr1.
“Among the 15 most affected regions were DNA elements proximal to genes such as Il1b, Mreg, Cdh26, Cdh23, Cd83, Ccrl2, and Egr1.”
Quote in the paperNot a substantial claim - Findingown data
The syntenic region of the mouse Il1b Peak5 enhancer was the most accessible region within the human IL1B locus.
“We focused on the human IL1B locus and found that the syntenic region of the mouse Il1b Peak5 enhancer was the most accessible region within the locus (Fig. 4Q).”
Quote in the paperSubstantial claim - Findingown data
Fibroblast cluster 3 lacked enrichment for Postn or Meox1.
“and lacked enrichment for Postn or Meox1 (Fig. 5M).”
Quote in the paperNot a substantial claim - Findingown data
Fibroblast cluster 1 was enriched for gene programs linked to profibrotic functions.
“along with enrichment for gene programs linked to profibrotic functions (Extended Data Fig. 11C,D)”
Quote in the paperSubstantial claim - Findingown data
CRISPR deletions revealed the precise stress-dependent regulatory element controlling Il1b expression.
“and a series of CRISPR deletions revealed the precise stress-dependent regulatory element that controls Il1b expression.”
Quote in the paperSubstantial claim - Findingown data
Sixty-one fibroblast genes were affected by both JQ1 and immune-specific Brd4 deletion, including profibrotic markers Postn, Meox1 and Thbs4.
“However, 61 fibroblast genes were affected by both perturbations, including the profibrotic markers Postn, Meox1, and Thbs4 (Extended Data Fig. 3K).”
Quote in the paperSubstantial claim - Findingown data
Fibroblast cluster 3 was predominantly derived from anti-IL1B-treated hearts.
“unlike cluster 3, which was predominantly from anti-IL1B treated hearts”
Quote in the paperNot a substantial claim - Findingown data
Thbs4 was specifically expressed in fibroblast cluster 4.
“(the latter specifically expressed in cluster 4)”
Quote in the paperNot a substantial claim - Findingown data
Il1b deletion in Cx3cr1-expressing cells markedly downregulated Postn, Meox1, and many other genes associated with fibroblast activation.
“Postn, Meox1, and many other genes associated with fibroblast activation were markedly downregulated in fibroblasts upon Il1b deletion in Cx3cr1-expressing cells”
Quote in the paperSubstantial claim - Findingown data
Fibroblast cluster 1 was characterized by elevated expression of profibrotic markers including Postn and Meox1.
“Cluster 1, characterized by elevated expression of profibrotic markers including Postn and Meox1”
Quote in the paperSubstantial claim - Findingown data
GO analysis of fibroblast genes significantly downregulated in TAC Il1b-KO versus TAC (n=690) revealed enrichment for profibrotic gene programs.
“GO analysis of the fibroblast genes significantly downregulated in TAC Il1b-KO versus TAC (n=690) revealed enrichment for profibrotic gene programs”
Quote in the paperSubstantial claim - Findingown data
GO analysis of genes significantly upregulated in fibroblasts from IgG versus anti-IL1B treated animals (n=469) identified extracellular matrix remodeling as the top enriched program.
“GO analysis of the significantly upregulated genes in fibroblasts in IgG versus anti-IL1B treated animals (n=469) identified as top enriched gene programs those associated with extracellular matrix remodeling”
Quote in the paperSubstantial claim - Findingown data
JQ1 administration resulted in more downregulated fibroblast genes (n=375) than immune-specific Brd4 deletion (n=137).
“As expected, JQ1 administration resulted in more downregulated genes (n=375) than immune-specific Brd4 deletion (n=137) (Extended Data Fig. 3K).”
Quote in the paperNot a substantial claim - Findingown data
DE analysis between TAC and TAC-Brd4KO in major cardiac cell populations showed similar numbers of dysregulated genes in myeloid cells (n=351) and fibroblasts (n=310), with far fewer in other cell types.
“DE analysis between the TAC and TAC-Brd4KO conditions in each major cardiac cell population demonstrated a similar number of dysregulated genes in myeloid cells (n=351) and fibroblasts (n=310), with far fewer in other cell types (Fig. 3D).”
Quote in the paperSubstantial claim - Findingown data
Deletion of Brd4 in infiltrating, but not resident, Cx3Cr1-positive macrophages is associated with improved cardiac function in murine heart failure.
“We show that deletion of Brd4 in infiltrating, but not resident, Cx3Cr1-positive macrophages is associated with improved cardiac function in murine heart failure.”
Quote in the paperSubstantial claim - Findingown data
Single-cell RNA sequencing of sorted cardiac fibroblasts from TAC Il1bflox/flox and Cx3cr1CreERT2; Il1bflox/flox mice at 10 days captured 19,787 cells expressing only fibroblast markers across 10 transcriptional clusters.
“We captured 19,787 cells expressing only fibroblast markers (Extended Data Fig. 11B) that encompassed 10 transcriptional clusters”
Quote in the paperSubstantial claim - Findingown data
CUT&RUN from sorted CX3CR1-positive cells showed that after cardiac stress, peaks 1, 2, 5 and 6 recruited BRD4.
“CUT&RUN from sorted CX3CR1-positive cells demonstrated that upon cardiac stress, peaks 1, 2, 5, and 6 exhibited recruitment of BRD4 (Fig. 4L).”
Quote in the paperSubstantial claim - Findingown data
Fibroblast clusters 4 and 6 were less represented in hearts treated with anti-IL1B than in IgG-treated hearts.
“Clusters 4 and 6 showed reduced fibroblast representation in hearts treated with anti-IL1B”
Quote in the paperSubstantial claim - Findingown data
GO analysis of genes upregulated in fibroblast clusters 3 and 5 revealed the same biological processes as the most enriched terms.
“GO analysis of genes upregulated in clusters 3 and 5 (those over-represented by fibroblasts from the anti-IL1B antibody treatment) revealed the same biological processes as most enriched”
Quote in the paperSubstantial claim - Findingown data
Among seven fibroblast clusters, clusters 4 and 6 were enriched for fibroblast stress genes including Postn, Meox1, and Thbs4.
“Among the 7 clusters identified, clusters 4 and 6 exhibited enrichment in fibroblast stress genes such as Postn, Meox1 and Thbs4”
Quote in the paperSubstantial claim - Findingown data
Genes upregulated in TAC-Brd4KO versus TAC (n=112) were enriched for vascular development, angiogenesis and VEGF response terms.
“In contrast, genes upregulated in TAC-Brd4KO versus TAC (n=112) were instead enriched with terms related to vascular development, angiogenesis, and response to VEGF (Extended Data Fig. 3J).”
Quote in the paperSubstantial claim - Findingown data
Fibroblast clusters 4 and 6 were associated with profibrotic gene programs related to extracellular matrix and collagen fibril organization.
“were associated with profibrotic gene programs related to extracellular matrix and collagen fibril organization (Extended Data Fig. 10F).”
Quote in the paperNot a substantial claim - Findingown data
GO terms of genes upregulated with IL1B neutralization (n=167) were enriched for angiogenesis and response to VEGF programs.
“the GO terms of genes upregulated with IL1B neutralization (n=167) were enriched with programs related to angiogenesis and response to VEGF”
Quote in the paperSubstantial claim - Findingown data
Deletion of Brd4 in Cx3cr1-expressing cells caused a significant decrease in the proinflammatory transcriptional response in monocyte-derived macrophages.
“We observed not only a significant decrease in the proinflammatory transcriptional response in the monocyte-derived macrophages”
Quote in the paperSubstantial claim - Findingown data
In the merged analysis, cluster 1 was depleted in cells from Anti-IL1B treatment and Il1b genetic deletion conditions.
“cluster 1 was depleted in cells from the Anti-IL1B treatment and Il1b genetic deletion conditions”
Quote in the paperSubstantial claim - Findingown data
LPS triggered upregulation of Il1b expression in control WT clones.
“Lipopolysaccharides (LPS) triggered upregulation of Il1b expression in control WT clones (Fig. 4M).”
Quote in the paperSubstantial claim - Findingown data
In the same TAC mouse model, IL1B neutralization reduced fibrosis compared with IgG control.
“reduced fibrosis (Extended Data Fig. 10A)”
Quote in the paperSubstantial claim - Findingown data
Motif enrichment analysis of cluster 5 compared with cluster 2 showed the greatest enrichment for the MEOX1 motif.
“Motif enrichment analysis of cluster 5, marked by high accessibility scores for genes upregulated in TAC versus TAC-Brd4KO (Fig. 3M) such as Postn and Meox1 (Fig. 3L), compared to cluster 2 which was over-represented by TAC-Brd4KO fibroblasts (Fig. 3M,O), revealed the greatest enrichment for the MEOX1 motif (Fig. 3P).”
Quote in the paperSubstantial claim - Findingown data
Fibroblasts express Il1r1, the receptor to which IL1B binds.
“Importantly, fibroblasts express Il1r1, the receptor to which IL1B binds (Extended Data Fig. 9A,B).”
Quote in the paperSubstantial claim - Findingown data
GO analysis of genes upregulated in TAC versus TAC-Brd4KO fibroblasts (n=198) was enriched for profibrotic programs such as extracellular matrix and collagen fibril organization.
“GO analysis of the significantly upregulated genes in TAC versus TAC-Brd4KO fibroblasts (n=198) (Extended Data Fig. 3I, top 50 shown) was enriched for profibrotic gene programs such as extracellular matrix and collagen fibril organization (Fig. 3H).”
Quote in the paperSubstantial claim - Findingown data
Among 748 identified super-enhancers, 162 showed strong TAC-induced BRD4 binding (LogFC>2 over Sham).
“Among the 748 identified super-enhancers, 162 exhibited strong TAC-induced BRD4 binding (LogFC>2 over Sham) (Extended Data Fig. 6I).”
Quote in the paperSubstantial claim - Findingown data
IL1B neutralization downregulated expression of Postn, Meox1, and other activated fibroblast markers.
“the expression of Postn and Meox1, and other activated fibroblast markers, was downregulated with IL1B neutralization”
Quote in the paperSubstantial claim - Findingown data
In mice subjected to transverse aortic constriction, treatment with IL1B neutralizing antibodies every three days for 30 days significantly improved cardiac function compared with IgG control.
“IL1B neutralization significantly increased cardiac function (Fig. 5H)”
Quote in the paperSubstantial claim - Findingown data
siRNA knockdown of p65/RELA abolished TGFB/IL1B-induced MEOX1 activation.
“siRNA knockdown of p65/RELA (Extended Data Fig. 9R) abolished TGFB/IL1B-induced MEOX1 activation (Fig. 5F).”
Quote in the paperSubstantial claim - Findingown data
Cloning the human MEOX1 cis-element into a luciferase reporter showed synergistic coregulation by BRD4 and p65/RELA.
“We cloned this cis-element into a luciferase reporter and found synergistic coregulation by BRD4 and p65/RELA (Fig. 5E).”
Quote in the paperSubstantial claim - Findingown data
Brd4 deletion caused a global reduction in accessibility of TAC-induced gene programs to levels similar to Sham.
“Plotting this accessibility score across samples revealed that Brd4 deletion caused a global reduction in accessibility of TAC-induced gene programs to levels similar as Sham (Fig. 4F).”
Quote in the paperSubstantial claim - Findingown data
Systemic IL1B inhibition or targeted Il1b deletion in Cx3cr1-positive cells prevented stress-induced MEOX1 expression and fibroblast activation.
“Systemic IL1B inhibition or targeted Il1b deletion in Cx3cr1-positive cells prevented stress-induced MEOX1 expression and fibroblast activation.”
Quote in the paperSubstantial claim - Findingown data
Merging scRNA-seq data from fibroblasts in the TAC IgG/TAC Anti-IL1B and TAC/TAC Il1b-KO experiments yielded 7 transcriptional clusters.
“Merging the scRNA-seq data from fibroblasts in both the TAC IgG/TAC Anti-IL1B (Fig. 5J) and TAC/TAC Il1b-KO (Fig. 5Q) experiments yielded 7 transcriptional clusters”
Quote in the paperSubstantial claim - Findingown data
Differential accessibility analysis between TAC and TAC-Brd4KO identified 460 sites with reduced chromatin accessibility in fibroblasts after Brd4 deletion in Cx3cr1-expressing cells.
“Differential accessibility analysis between TAC and TAC-Brd4KO identified 460 sites with reduced chromatin accessibility in fibroblasts upon Brd4 deletion in Cx3cr1-expressing cells.”
Quote in the paperSubstantial claim - Findingown data
One set of dynamic super-enhancers increased significantly with TAC and decreased after Cx3cr1-specific Brd4 deletion (Wilcoxon p-value < 1e−5 in all cases).
“ones that increase significantly (Wilcoxon p-value < 1e−5 in all cases) with TAC and decrease with Cx3cr1-specific Brd4 deletion”
Quote in the paperSubstantial claim - Findingown data
Cluster 3 cells have high chromatin accessibility at both CX3CR1 and IL1B genes.
“the cluster with high accessibility for both CX3CR1 and IL1B genes”
Quote in the paperSubstantial claim - Findingreasoning
The profibrotic response was decreased in this context.
“In this context, the profibrotic response was decreased”
Quote in the paperSubstantial claim - Findingown data
Via a specific p65/RELA-dependent enhancer, IL1B controls activation of MEOX1.
“and that via a specific p65/RELA-dependent enhancer, it controls the activation of MEOX1”
Quote in the paperSubstantial claim - Findingnone given
The paper identified exact stress-activated cis-elements that regulate Il1b activation in heart disease.
“Here, we identified the exact stress-activated cis-elements that regulate Il1b activation in heart disease.”
Quote in the paperSubstantial claim - Findingown data
HOMER's top de novo motif was strongly enriched, with 58.5% of target regions containing it versus 5.23% of background regions (Homer p-value = 1e-2595).
“The top identified de novo motif was highly enriched, occurring in 58.5% of target regions as compared to 5.23% of background regions (Homer p-value = 1e-2595).”
Quote in the paperNot a substantial claim - Interpretationown data
The contribution of Brd4 to TAC-induced cardiac dysfunction mainly comes from circulating monocyte-derived macrophages in the heart.
“indicating that Brd4 contribution to TAC-induced cardiac dysfunction primarily arises from circulating monocyte-derived macrophages in the heart.”
Quote in the paperSubstantial claim - Interpretationown data
The large number of cardiac-function-correlated genes in myeloid cells indicates that this compartment is highly transcriptionally plastic under stress and BET inhibition.
“indicating a high degree of transcriptional plasticity in response to stress and BET inhibition (Fig. 1E).”
Quote in the paperSubstantial claim - Interpretationown data
The similar GO enrichment suggests common fibroblast transcriptional changes associated with cell-type-specific Brd4 deletion in Cx3cr1-expressing cells and antibody-mediated IL1B neutralization.
“suggesting common fibroblast transcriptional changes associated with cell-type specific Brd4 deletion in Cx3cr1-expressing cells and antibody-mediated IL1B neutralization.”
Quote in the paperSubstantial claim - Interpretationown data
IL1B signaling has a critical role in controlling fibroblast activation in response to cardiac stress.
“underscoring the critical role of IL1B signaling in controlling fibroblast activation in response to cardiac stress.”
Quote in the paperSubstantial claim - Interpretationown data
IL1B antibody-mediated neutralization is sufficient to improve cardiac function in heart disease.
“and that IL1B antibody-mediated neutralization is sufficient to improve cardiac function in heart disease.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from the mouse TAC model and anti-IL1B treatment translate to human heart disease.
- Interpretationreasoning
Cis-regulatory elements, such as the MEOX1 enhancer, can function as hubs to process profibrotic and proinflammatory signaling.
“Our discoveries highlight how cis-regulatory elements, such as the MEOX1 enhancer, can function as hubs to process profibrotic and proinflammatory signaling”
Quote in the paperSubstantial claim - Interpretationown data
IL1B was essential for fibroblast activation in heart failure pathogenesis.
“We found that IL1B was essential for fibroblast activation in heart failure pathogenesis”
Quote in the paperSubstantial claim - Interpretationreasoning
In response to stress, BRD4 in Cx3cr1-expressing cells controls expression of paracrine signals, such as IL1B, that drive activation of tissue fibroblasts and fibrosis.
“suggesting that in response to stress, BRD4 in Cx3cr1-expressing cells controls the expression of paracrine signals, such as IL1B, that drive activation of tissue fibroblasts and fibrosis.”
Quote in the paperSubstantial claim - Interpretationown data
IL1B from Cx3cr1-expressing myeloid cells is a critical modulator of stress-induced fibroblast states.
“Our data suggest that IL1B from Cx3cr1-expressing myeloid cells is a critical modulator of stress-induced fibroblast states”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 12
- May combine two claims. 42
Classified as probably not a substantial claim. May combine two claims.
PremisecitationBET proteins act as transcriptional co-activators, and their inhibition is linked to protection in heart failure models.
“As BET proteins are transcriptional co-activators and their inhibition is associated with protection in heart failure models6-8”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [6] Anand, P. et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 154, 569–582 (2013). source
- cites [7] Spiltoir, J. I. et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 63, 175–179 (2013). source
- cites [8] Duan, Q. et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aah5084 (2017). source
May combine two claims.
Findingown dataResident macrophage markers Lyve1, Folr2 and Timd4 were enriched in myeloid clusters 4 and 6, with Lyve1 and Folr2 also marking clusters 0, 2 and 3.
“Expression of the resident macrophage markers15,16 Lyve1, Folr2 and Timd4 were enriched in clusters 4 and 6, with Lyve1 and Folr2 also marking clusters 0, 2 and 3 (Fig. 1J and Extended Data Fig. 1C-E).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [15] Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat. Immunol. 20, 29–39 (2019). source
The Discussion identifies TIMD4 and LYVE1 as resident cardiac macrophage markers. The Results section on recruited cardiac macrophage plasticity lists Folr2 among genes associated with mature macrophages, but does not specifically establish it as a resident marker. The cluster-enrichment pattern is presented as the citing paper’s own figure result, not as a finding attributed to this source. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [16] Dick, S. A. et al. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci. Immunol. 7, eabf7777 (2022). source
Classified as probably not a substantial claim.
PremisecitationMyeloid cells can amplify the stress response in a non-cell autonomous manner through secreted factors.
“Given the ability of myeloid cells to act as non-cell autonomous amplifiers of the stress-response through secreted factors12-14”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [12] Korf-Klingebiel, M. et al. Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco/endoplasmic reticulum Ca2+-ATPase expression in cardiomyocytes. Circulation 144, 1227–1240 (2021). source
- cites [13] Reboll, M. R. et al. EMC10 (endoplasmic reticulum membrane protein complex subunit 10) is a bone marrow-derived angiogenic growth factor promoting tissue repair after myocardial infarction. Circulation 136, 1809–1823 (2017). source
- cites [14] Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C. & Frangogiannis, N. G. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 176, 2177–2187 (2010). source
The Discussion describes inflammatory monocytes secreting cytokines and explains how inflammatory mediators may affect cardiomyocytes and worsen remodeling after myocardial infarction. This supports an effect on other cells through secreted factors, but the paper does not establish that myeloid cells amplify a general stress response. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationBecause Cx3cr1 is not expressed in fibroblasts and Brd4 is not deleted in that population, the fibroblast gene expression changes reflect a non-cell autonomous effect.
“As Cx3cr1 is not expressed in fibroblasts26 (Extended Data Fig. 1A), and therefore Brd4 is not deleted in this cell population (Extended Data Figs. 2B and 3B-D), the fibroblast gene expression changes reflect a non-cell autonomous effect.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [26] Heidt, T. et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ. Res. 115, 284–295 (2014). source
May combine two claims.
Findingown dataMotif analysis of these regions revealed enrichment for profibrotic TFs such as SMADs and MEOX1, and for RUNX1 and REL, regulators of proinflammatory responses.
“Motif analysis of these regions revealed enrichment for TFs critical for profibrotic responses in heart failure, such as SMADs27 and MEOX14, as well as RUNX1 and REL, regulators of proinflammatory responses27 (Extended Data Fig. 4D).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [27] Hanna, A., Humeres, C. & Frangogiannis, N. G. The role of Smad signaling cascades in cardiac fibrosis. Cell. Signal. 77, 109826 (2021). source
The ‘Smad signaling cascades in fibroblasts’ section (page not provided) describes Smad3 as a central signal promoting cardiac myofibroblast conversion and extracellular-matrix production, supporting the profibrotic role attributed to SMADs. The passages retrieved for RUNX1 and REL do not establish their roles in proinflammatory responses. The motif enrichment is presented as the citing paper’s own analysis, and MEOX1 carries a different citation. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationIn human disease, stress-induced signaling converges in the nucleus, where chromatin receives, processes and amplifies upstream inputs, leading to altered gene expression, maladaptive cell state transitions and organ dysfunction.
“In human disease, stress-induced signaling converges in the nucleus, where chromatin receives, processes, and amplifies upstream inputs, ultimately leading to altered gene expression, maladaptive cell state transitions and organ dysfunction1.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [1] Badeaux, A. I. & Shi, Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14, 211–224 (2013). source
The Introduction (page not available) describes signaling reaching the nucleus and changing gene expression, while “Signal integration on histones” describes chromatin integrating multiple inputs into a transcriptional response. The Conclusion and perspectives links epigenetic signaling to disease and gives cancer-cell state changes as an example. It does not establish the full claimed chain from stress-induced signaling through chromatin amplification to organ dysfunction; its account of integration is partly speculative. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataMeox1 transcription is sensitive to BET inhibition, confirmed in human cardiac fibroblasts treated with IL1B and TGFB.
“As our previous work demonstrated that Meox1 transcription is sensitive to BET inhibition4, which we confirmed in human cardiac fibroblasts treated with IL1B and TGFB (Extended Data Fig. 9Q)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438–443 (2021). source
May combine two claims.
Findingown dataSingle-cell RNA sequencing of non-cardiomyocytes from mouse hearts captured 41,626 cells and resolved 20 transcriptional clusters, including fibroblasts, myeloid cells, endothelial cells and pericytes.
“We captured 41,626 cells from Sham, TAC vehicle-treated (TAC), or TAC JQ1-treated (TAC JQ1) hearts, and identified 20 transcriptional clusters, including fibroblasts (Dcn+), myeloid cells (Lyz2+), endothelial cells (Fabp4+) and pericytes (Abcc9+) (Fig. 1C and Extended Data Fig. 1A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIl1b expression was enriched in cluster 4 and was sensitive to cardiac stress and Brd4 deletion in Cx3cr1-positive cells.
“The expression of the proinflammatory cytokine Il1b (Interleukin-1β) was particularly interesting as it was enriched in cluster 4 (Fig. 2I,J) and sensitive to cardiac stress and Brd4 deletion in Cx3cr1-positive cells (Fig. 2K).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTop cluster 4 marker genes included MHC class 2 glycoproteins along with Il1b and Ccr2, both enriched in cluster 4 even relative to cluster 3.
“Among the top cluster 4 marker genes were several encoding the major histocompatibility complex (MHC) class 2 glycoproteins (also present in cluster 3) along with Il1b and Ccr2, both of which were enriched in cluster 4, even when compared to cluster 3 (Fig. 2G).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the myeloid compartment, 22 genes were anti-correlated and 24 were positively correlated with cardiac function at a stringent threshold.
“We ranked all genes expressed in the myeloid compartment by their correlation score using a stringent statistical threshold (p < 1e−6, corresponding to a correlation score < ± 5) and identified 22 anti-correlated (Fig. 1F) and 24 positively correlated (Fig. 1F and Extended Data Fig. 1B) with cardiac function.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCluster 4 expanded from Sham to TAC (9.3% to 14.9%) and was reduced after Brd4 deletion (14.9% to 2.5%).
“We found that cluster 4 was expanded from Sham to TAC (9.3% to 14.9%) and reduced upon Brd4 deletion (14.9% to 2.5%) (Fig. 2E and Extended Data Fig. 2L).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFlow cytometry 7 days after TAC showed no significant effect of Brd4 deletion on immune cell, monocyte or macrophage numbers, but a trend toward fewer monocytes.
“We assessed the impact of Brd4 deletion in Cx3cr1-positive cells on monocyte infiltration post-TAC by flow cytometry 7 days after surgery which showed no significant effect on immune cell, monocyte, or macrophage numbers, but a trend suggesting a potential reduction in monocytes (Extended Data Fig. 2M).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBy scRNA-seq, JQ1 reduced Ccr2-expressing infiltrating macrophages but did not affect Timd4-, Lyve1- and Folr2-expressing resident macrophages.
“By scRNA-seq, JQ1 reduced cells expressing Ccr2 (infiltrating macrophages) but did not affect cells expressing Timd4, Lyve1, and Folr2 (resident macrophages) (Extended Data Fig. 1G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCx3cr1 and Il1b were co-expressed in cluster 1, which was enriched in TAC and depleted in Sham and TAC JQ1 conditions.
“Cx3cr1 and Il1b were co-expressed in cluster 1 (Fig. 1J), which was enriched in cells from TAC and depleted in Sham and TAC JQ1 conditions (Extended Data Fig. 1F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSingle-cell RNA sequencing of sorted cardiac CD45-positive cells processed 10,450 immune cells and identified 16 transcriptomic clusters.
“We processed 10,450 immune cells and identified 16 transcriptomic clusters.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCx3cr1 and Il1b increased in TAC compared with Sham and were downregulated by JQ1.
“Consistent with Cx3cr1 and Il1b expression being negatively correlated with cardiac function (Fig. 1F), both genes were increased in TAC compared to Sham, and downregulated by JQ1 treatment (Fig. 1K).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCx3cr1 accessibility was almost entirely in cluster 4, as was Il1b accessibility.
“Interestingly, Cx3cr1 accessibility was almost entirely in cluster 4, as was accessibility of Il1b, one of the most dynamically regulated genes in the scRNA-seq analysis (Fig. 4D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOf the 15 super-enhancers with dynamic chromatin accessibility, 10 had greater BRD4 binding in TAC, including large enhancers proximal to Il1b, Mreg, Cdh26 and Cd83.
“Of the 15 super-enhancers with dynamic chromatin accessibility across conditions (Fig. 4I, top right quadrant), 10 had greater BRD4 binding in TAC, including the large enhancers proximal to Il1b, Mreg, Cdh26, and Cd83 (Extended Data Fig. 6J).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSeveral p65/RELA motifs were present in this 2.7 kb distal region, and p65/RELA ChIP-seq on human cardiac fibroblasts showed direct binding at the human MEOX1 enhancer.
“Several motifs for p65/RELA were present within this 2.7kb distal region (Extended Data Fig. 9P), and p65/RELA ChIP-seq on human cardiac fibroblasts revealed direct binding at the MEOX1 human enhancer (Fig. 5D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL1B significantly increased αSMA-positive fibers, and this increase was greater when IL1B was combined with TGFB than with TGFB alone.
“IL1B led to a significant increase in α-smooth muscle (αSMA)-positive fibers, which was further increased when used in combination with TGFB compared to TGFB alone (Extended Data Fig. 9D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGenes significantly upregulated in TAC versus TAC-Brd4KO showed decreased accessibility in TAC-Brd4KO, indicating concordance between transcriptional and chromatin changes.
“We then scored accessibility across the dysregulated fibroblast genes in our snRNA-seq analysis and found that genes significantly upregulated in TAC versus TAC-Brd4KO displayed decreased accessibility in TAC-Brd4KO, indicating concordance between transcriptional and chromatin changes (Fig. 3M,N).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTAC cells were more numerous in the Cx3cr1/Il1b-accessible cluster 4 than Sham cells, and Brd4 deletion was associated with a decrease in its composition.
“Cells from the TAC condition were greater in number in the Cx3cr1/Il1b accessible Cluster 4 relative to Sham, and Brd4 deletion was associated with a decrease in its composition (Extended Data Fig. 5C,D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMost CRISPR deletions did not significantly affect LPS-induced Il1b induction, but deletion of peaks 5 and 6 reduced stress-induced expression.
“While most of the CRISPR deletions did not significantly affect LPS-induced Il1b induction, the deletion of peaks 5 and 6 reduced stress-induced expression (Fig. 4M).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHuman myeloid cluster 3 had strong accessibility for CX3CR1, IL1B and CCR2, while clusters 5, 6 and 8 had high accessibility for TIMD4 and LYVE1.
“with cluster 3 associated with strong accessibility for CX3CR1, IL1B and CCR2 (Fig. 4P and Extended Data Fig. 8A), while clusters 5, 6 and 8 were associated with high accessibility for the resident macrophage markers TIMD4 and LYVE1 (Extended Data Fig. 8A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIL1R1 knockdown impaired contractility triggered by IL1B and by TGFB+IL1B, but did not reduce contractility when TGFB was used alone.
“Knockdown of IL1R1 impaired the contractility triggered by IL1B and TGFB+IL1B (Extended Data Fig. 9F-J), but had no effect in reducing contractility when TGFB was used alone (Extended Data Fig. 9I).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSingle nuclei RNA-seq of hearts from TAC or TAC-Brd4KO animals processed 28,107 nuclei into 17 transcriptomic clusters covering major cardiac cell populations.
“A group of 28,107 nuclei encompassing all the major cardiac cell populations was processed into 17 transcriptomic clusters (Fig. 3B, Extended Data Fig. 3A).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataIn the merged analysis, cluster 0 was the largest and equally distributed between samples.
“While cluster 0, the largest in number, was equally distributed between samples”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWithin the fibroblast population, 7 transcriptional clusters encompassing 7,388 cells were identified, with TAC and TAC-Brd4KO fibroblasts clustering separately.
“Within the fibroblast population, we identified 7 transcriptional clusters encompassing 7,388 cells (Fig. 3E), with TAC and TAC-Brd4KO fibroblasts clustering separately (Fig. 3F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datascATAC-seq of sorted CD45-positive cells from Sham, TAC and TAC-Brd4KO identified 21 clusters, and C1qa, Cd163 and Cd14 gene scores identified the monocyte/macrophage population, which was also accessible for Cx3cr1.
“We identified 21 clusters, and gene score signals of C1qa, Cd163, and Cd14 identified the monocyte/macrophage population, which was also accessible for Cx3cr1 (Extended Data Fig. 5A,B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn vivo, antibody-mediated IL1B neutralization improved cardiac function and tissue fibrosis in heart failure.
“In vivo, antibody-mediated IL1B neutralization improved cardiac function and tissue fibrosis in heart failure.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataConditional deletion of Brd4 in infiltrating Cx3cr1-positive macrophages ameliorates heart failure and significantly reduces fibroblast activation.
“Here, we show that conditional deletion of the transcriptional co-activator Brd4 in infiltrating Cx3cr1-positive macrophages ameliorates heart failure and significantly reduces fibroblast activation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFibroblast cluster 6 specifically expressed activation genes such as Postn, Meox1, Comp, Cilp, Mfap4 and Thbs4, and was depleted of TAC-Brd4KO fibroblasts.
“Cluster 6 was associated with specific expression of fibroblast activation genes such as Postn, Meox1, Comp, Cilp, Mfap4, and Thbs4 (Fig. 3G, Extended Data Fig. 3E-G), and was depleted of TAC-Brd4KO fibroblasts (Extended Data Fig. 3H).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA second set of dynamic super-enhancers decreased with TAC and increased after Cx3cr1-specific Brd4 deletion.
“ones that decrease with TAC and increase with the deletion”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataThe analysis yielded 748 large enhancers.
“This results in 748 large enhancers.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataBrd4 mRNA was significantly reduced in Cx3cr1CreERT2;Brd4flox/flox versus Brd4flox/flox animals only in CX3CR1-positive cells, with no effect in cardiomyocytes, fibroblasts or endothelial cells.
“Brd4 mRNA levels were significantly reduced in Cx3cr1CreERT2;Brd4flox/flox versus Brd4flox/flox animals only in CX3CR1Pos cells, while Brd4 expression was not affected in CMs, fibroblasts or endothelial cells (Extended Data Fig. 2A,B).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataNeutralizing IL1B attenuated the increased fibroblast contractility caused by LPS-treated medium, demonstrating that myeloid-cell-derived IL1B modulates fibroblast contractile phenotype in a paracrine manner.
“While the LPS-treated medium with IgG antibody increased fibroblast contractility, neutralizing IL1B significantly attenuated it, demonstrating that IL1B from myeloid cells modulates fibroblast contractile phenotype in a paracrine fashion (Fig. 5A).”
Quote in the paperSubstantial claim- Rests on an assumption: IL1B is a secreted factor that can influence other cell states through paracrine signaling.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown datascATAC-seq annotated all major cell populations identified by snRNA-seq.
“As expected, scATAC-seq annotated all major cell populations identified by snRNA-seq (Fig. 3I and Extended Data Fig. 4A).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataIl1b was one of the genes most sensitive to Brd4 deletion in Cx3cr1-expressing cells, suggesting direct regulation by BRD4.
“Moreover, Il1b was one of the most sensitive genes to Brd4 deletion in Cx3cr1-expressing cells, suggesting direct regulation by BRD4 (Fig. 2H,K).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown datasiRNA-mediated downregulation of MEOX1 abolished the increased fibroblast contractility induced by IL1B plus TGFB, suggesting that fibroblast activation depends on MEOX1.
“siRNA-mediated downregulation of MEOX1 abolished the increased fibroblast contractility induced by the combination of IL1B and TGFB (Fig. 5C and Extended Data Fig. 9L-O), suggesting dependency on MEOX1 for the activation of fibroblasts.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataBRD4-dependent crosstalk between a specific immune cell subset and fibroblasts through IL1B reveals how inflammation drives profibrotic cell states and supports strategies to modulate this process in heart disease and other chronic inflammatory disorders with tissue remodeling.
“The elucidation of BRD4-dependent crosstalk between a specific immune cell subset and fibroblasts through IL1B reveals how inflammation drives profibrotic cell states and supports strategies that modulate this process in heart disease and other chronic inflammatory disorders featuring tissue remodeling.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataOne sample in one condition was excluded from fibrosis analysis because its fibrosis percentage was greater than two standard deviations above the mean across all data points.
“One sample in one condition was excluded because the fibrosis percentage was greater than two standard deviations above the mean when considering all the data points across all conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenEchocardiography analyses were performed blinded, with mice assigned an alphanumeric code.
“All echocardiography analyses were performed blinded (mice were assigned an alphanumeric code).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningTo address variance from using few cells, the authors restricted coverage analysis to regions where at least two samples had at least one read and used a minimum coverage threshold of 4e−6.
“To control for the large variance that can result from deriving coverage from a small number of cells, we only considered signal in regions in which at least two different samples had at least one read, and set a minimum threshold of 4e−6 for detectability of coverage”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenFibrosis analysis was performed blinded, with samples labeled by an alphanumeric code.
“A blinded approach (labeling samples with an alphanumeric code) was implemented for analyzing fibrosis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll animal protocols were approved by the Institutional Animal Care and Use Committees at the University of California, San Francisco and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
“All protocols concerning animal use were approved by the Institutional Animal Care and Use Committees at the University of California, San Francisco and conducted in strict accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataLuciferase constructs were tested in three technical replicates and at least three biological replicates.
“Each construct was transfected in three technical replicates and at least 3 biological replicates were performed.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Before this study, the mechanism by which organ-level stress is sensed by cells to trigger downstream fibroblast activation was unknown.
“However, the mechanism by which organ-level stress is sensed by cells to trigger downstream fibroblast activation remains unknown.”
The paper relies on this without support.
IL1B is a secreted factor that can influence other cell states through paracrine signaling.
“Importantly, Il1b encodes a secreted factor (IL1B) that can influence other cell states via paracrine signaling.”
The paper relies on this without support.
In response to stress, chromatin remodeling can alter expression of secreted factors and thereby influence neighboring cells through non-cell autonomous mechanisms.
“In response to stress, chromatin remodeling can alter the expression of secreted factors thus influencing neighboring cells through non-cell autonomous mechanisms and fueling pathological crosstalk between diverse cellular compartments.”
The paper relies on this without support.
The molecular mechanisms governing crosstalk between chronic inflammation and tissue fibrosis are poorly understood.
“Chronic inflammation and tissue fibrosis are common responses that worsen organ function, yet the molecular mechanisms governing their crosstalk are poorly understood.”
The paper relies on this without support.
Systemic neutralizing antibody administration blocked IL1B from various possible cellular sources.
“As systemic neutralizing antibody administration blocked IL1B from various possible cellular sources”
The paper relies on this without support.
Little is known about how inflammatory signals can influence fibroblast cell states in disease.
“little is known about how inflammatory signals can influence fibroblast cell states in disease.”
The paper relies on this without support.
Findings from the mouse TAC model and anti-IL1B treatment translate to human heart disease.
“IL1B antibody-mediated neutralization is sufficient to improve cardiac function in heart disease.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
JQ1 treatment can reversibly direct fibroblast activation away from the FAP/POSTN cell state, indicating therapeutic potential of targeting the differentiation and maturation of FAP-positive fibroblasts.
“The possibility that JQ1 treatment can reversibly direct fibroblast activation away from the FAP/POSTN cell state indicates the therapeutic potential of targeting the differentiation and maturation of FAP+ fibroblasts28,30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
In “BRD4 in Cx3cr1+ cells activates fibroblasts” (page unavailable), the paper reports that JQ1 downregulated fibroblast genes including the profibrotic marker Postn. Its introduction describes a reversible fibroblast-activation switch under BET inhibition, but the paper does not establish that JQ1 reversibly redirects a FAP/POSTN-defined cell state or specifically targets the differentiation and maturation of FAP-positive fibroblasts. (LLM, conf=0.84)
Experimental — accuracy not yet measuredThe Srivastava laboratory also showed that anti-IL-1β antibody treatment leads to fewer POSTN fibroblasts, improved cardiac function and decreased cardiac fibrosis.
“They also show that anti-IL-1β mAb treatment leads to fewer POSTN fibroblasts, improved cardiac function and decreased cardiac fibrosis30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
The section ‘IL1B inhibition improves heart function’ reports that anti-IL1B treatment in mice reduced the representation of Postn-enriched fibroblast clusters, improved cardiac function and reduced fibrosis. The Methods identify the treatment as an anti-IL1B antibody but do not specify that it was monoclonal, so the ‘mAb’ detail is not established by our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredThe Srivastava laboratory showed that Brd4 deletion in macrophages abrogates IL-1β signalling and suppresses fibroblast activation and fibrosis through a MEOX1-dependent regulatory mechanism in a pressure-overload model of heart failure.
“Consistent with our findings, the Srivastava laboratory has shown that Brd4 deletion in macrophages abrogates IL-1β signalling and suppresses fibroblast activation and fibrosis through a MEOX1-dependent regulatory mechanism in a pressure-overload model of HF30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
In “BRD4 function in Cx3cr1+ cells during heart failure,” Brd4 deletion in Cx3cr1-positive cells reduced fibrosis after pressure overload; “BRD4 in Cx3cr1+ cells activates fibroblasts” reports reduced profibrotic fibroblast programs. The paper also links IL1B to MEOX1-dependent fibroblast activation, but “BRD4 drives proinflammatory transcription” reports decreased Il1b expression after Brd4 deletion, not that IL-1β signalling was abrogated. (LLM, conf=0.86)
Experimental — accuracy not yet measuredPrevious and concurrent work highlighted the functional role of this gene regulatory network in cardiac fibrosis.
“Indeed, previous and concurrent work has highlighted the functional role of this gene regulatory network in cardiac fibrosis28–30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
Concurrent work established a role for MEOX1 in the pathogenesis of cardiac fibrosis.
“These findings are underscored by concurrent work establishing a role for MEOX1 in the pathogenesis of cardiac fibrosis30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
Concurrent work reported that anti-IL-1β antibody treatment improved cardiac function and reduced fibrosis in a TAC heart failure model.
“Consistent with these findings, concurrent work showed that anti-IL-1β mAb treatment improved cardiac function and reduced fibrosis in a TAC HF model30.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Overlapping p-value reporting rules conflict
MinorA p-value between 0.0001 and 0.001 satisfies both stated rules: one requires its exact value, while the other reports it as P<0.0001, which would be false.
“In all figures, the exact p-value is indicated if the p-value is higher than 0.0001.”
“For values lower than 0.001 we indicate P<0.0001.”
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · see citing works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482 · see citing works
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791 · see citing works
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · see citing works
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143 · see citing works
Gene set knowledge discovery with enrichr
Xie, Z., Bailey, A., Kuleshov, M. V., Clarke, D. J. B., Evangelista, J. E., Jenkins, S. L., Lachmann, A., Wojciechowicz, M. L., Kropiwnicki, E., Jagodnik, K. M., et al. (2021) · Current Protocols · doi:10.1002/cpz1.90 · Cited by 3,451 · see citing works
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · see citing works
Liao, Y., Smyth, G. K., & Shi, W. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz114 · Cited by 2,965 · see citing works
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300 · see citing works
Phthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760 · see citing works
Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494 · see citing works
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis
Granja, J. M., Corces, M. R., Pierce, S. E., Bagdatli, S. T., Choudhry, H., Chang, H. Y., & Greenleaf, W. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00790-6 · Cited by 1,392 · see citing works
Cross-tissue organization of the fibroblast lineage
Buechler, M. B., Pradhan, R., Krishnamurty, A. T., Cox, C. B., Calviello, A. K., Wang, A. W., Yang, Y. A., Tam, L., Caothien, R. H., Roose‐Girma, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03549-5 · Cited by 1,073 · see citing works
Self-Renewing Resident Cardiac Macrophages Limit Adverse Remodeling Following Myocardial Infarction
Dick, S. A., Macklin, J. A., Nejat, S., Momen, A., Clemente-Casares, X., Althagafi, M. G., Chen, J., Kantores, C., Hosseinzadeh, S., Aronoff, L., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0272-2 · Cited by 883 · see citing works
Spatial multi-omic map of human myocardial infarction
(2020) · doi:10.1101/2020.12.08.411686 · Cited by 772 · see citing works
Spatial multi-omic map of human myocardial infarction
Kuppe, C., Ramirez Flores, R. O., Li, Z., Hayat, S., Levinson, R. T., Liao, X., Hannani, M. T., Tanevski, J., Wünnemann, F., Nagai, J. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05060-x · Cited by 772 · see citing works
Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., Mohan, J., Ivey, B., Hsiao, H.-M., Weinheimer, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314028 · Cited by 751 · see citing works
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658 · see citing works
Heidt, T., Courties, G., Dutta, P., Sager, H. B., Sebas, M., Iwamoto, Y., Sun, Y., Da Silva, N., Panizzi, P., van der Laan, A. M., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303567 · Cited by 607 · see citing works
An acute immune response underlies the benefit of cardiac stem cell therapy
Vagnozzi, R. J., Maillet, M., Sargent, M. A., Khalil, H., Johansen, A. K. Z., Schwanekamp, J. A., York, A. J., Huang, V. H., Nahrendorf, M., Sadayappan, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1802-2 · Cited by 547 · see citing works
Self-citationDick, S. A., Wong, A., Hamidzada, H., Nejat, S., Nechanitzky, R., Vohra, S., Mueller, B., Zaman, R., Kantores, C., Aronoff, L., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abf7777 · Cited by 538 · see citing works
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406 · see citing works
Self-citationTransforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 349 · see citing works
Pinto, A. R., Paolicelli, R., Salimova, E., Gospocic, J., Slonimsky, E., Bilbao-Cortes, D., Godwin, J. W., & Rosenthal, N. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036814 · Cited by 318 · see citing works
Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090759 · Cited by 301 · see citing works
Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis
Revelo, X. S., Parthiban, P., Chen, C., Barrow, F., Fredrickson, G., Wang, H., Yücel, D., Herman, A., & van Berlo, J. H. (2021) · Circulation Research · doi:10.1161/circresaha.121.319737 · Cited by 298 · see citing works
Targeting immune–fibroblast cell communication in heart failure
Amrute, J. M., Luo, X., Penna, V., Yang, S., Yamawaki, T., Hayat, S., Bredemeyer, A., Jung, I.-H., Kadyrov, F. F., Heo, G. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08008-5 · Cited by 298 · see citing works
Patel, B., Bansal, S. S., Ismahil, M. A., Hamid, T., Rokosh, G., Mack, M., & Prabhu, S. D. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.12.006 · Cited by 297 · see citing works
The BET family in immunity and disease
Wang, N., Wu, R., Tang, D., & Kang, R. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00384-4 · Cited by 295 · see citing works
Emerging roles for chromatin as a signal integration and storage platform
Badeaux, A. I., & Shi, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3545 · Cited by 291 · see citing works
Duan, Q., McMahon, S., Anand, P., Shah, H., Thomas, S., Salunga, H. T., Huang, Y., Zhang, R., Sahadevan, A., Lemieux, M. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5084 · Cited by 262 · see citing works
Self-citationLee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260 · see citing works
A transcriptional switch governs fibroblast activation in heart disease
Alexanian, M., Przytycki, P. F., Micheletti, R., Padmanabhan, A., Ye, L., Travers, J. G., Gonzalez-Teran, B., Silva, A. C., Duan, Q., Ranade, S. S., et al. (2021) · Nature · doi:10.1038/s41586-021-03674-1 · Cited by 238 · see citing works
Self-citationZhang, J., Tao, R., Campbell, K. F., Carvalho, J. L., Ruiz, E. C., Kim, G. C., Schmuck, E. G., Raval, A. N., da Rocha, A. M., Herron, T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09831-5 · Cited by 201 · see citing works
Link, V. M., Duttke, S. H., Chun, H. B., Holtman, I. R., Westin, E., Hoeksema, M. A., Abe, Y., Skola, D., Romanoski, C. E., Tao, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.018 · Cited by 182 · see citing works
Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation
Stratton, M. S., Bagchi, R. A., Felisbino, M. B., Hirsch, R. A., Smith, H. E., Riching, A. S., Enyart, B. Y., Koch, K. A., Cavasin, M. A., Alexanian, M., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315125 · Cited by 179 · see citing works
Self-citationDynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation
(2019) · doi:10.1101/563445 · Cited by 179 · see citing works
Self-citationBET acetyl-lysine binding proteins control pathological cardiac hypertrophy
Spiltoir, J. I., Stratton, M. S., Cavasin, M. A., Demos-Davies, K., Reid, B. G., Qi, J., Bradner, J. E., & McKinsey, T. A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.017 · Cited by 174 · see citing works
Self-citationThe role of Smad signaling cascades in cardiac fibrosis
Hanna, A., Humeres, C., & Frangogiannis, N. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109826 · Cited by 132 · see citing works
Transcription factor protein interactomes reveal genetic determinants in heart disease
González‐Terán, B., Pittman, M., Felix, F., Thomas, R., Richmond-Buccola, D., Hüttenhain, R., Choudhary, K., Moroni, E., Costa, M. W., Huang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.021 · Cited by 81 · see citing works
Self-citationBET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice
Auguste, G., Rouhi, L., Matkovich, S. J., Coarfa, C., Robertson, M. J., Czernuszewicz, G., Gurha, P., & Marian, A. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135922 · Cited by 77 · see citing works
Li, D., Wu, J., Bai, Y., Zhao, X., & Liu, L. (2014) · Journal of Visualized Experiments · doi:10.3791/51357 · Cited by 75 · see citing works
Korf-Klingebiel, M., Reboll, M. R., Polten, F., Weber, N., Jäckle, F., Wu, X., Kallikourdis, M., Kunderfranco, P., Condorelli, G., Giannitsis, E., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.053365 · Cited by 71 · see citing works
Padmanabhan, A., Alexanian, M., Linares-Saldana, R., González-Terán, B., Andreoletti, G., Huang, Y., Connolly, A. J., Kim, W., Hsu, A., Duan, Q., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047753 · Cited by 60 · see citing works
Self-citationReboll, M. R., Korf-Klingebiel, M., Klede, S., Polten, F., Brinkmann, E., Reimann, I., Schönfeld, H.-J., Bobadilla, M., Faix, J., Kensah, G., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029980 · Cited by 48 · see citing works
Rhee, A. J., & Lavine, K. J. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034412 · Cited by 46 · see citing works
BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy
Antolic, A., Wakimoto, H., Jiao, Z., Gorham, J. M., DePalma, S. R., Lemieux, M. E., Conner, D. A., Lee, D. Y., Qi, J., Seidman, J. G., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138687 · Cited by 41 · see citing works
Self-citationBET Bromodomain Proteins Regulate Transcriptional Reprogramming in Genetic Dilated Cardiomyopathy
(2020) · doi:10.1101/2020.02.09.940882 · Cited by 41 · see citing works
Self-citationExercise promotes a cardioprotective gene program in resident cardiac fibroblasts
Lighthouse, J. K., Burke, R. M., Velasquez, L. S., Dirkx, R. A., Aiezza, A., Moravec, C. S., Alexis, J. D., Rosenberg, A., & Small, E. M. (2019) · JCI Insight · doi:10.1172/jci.insight.92098 · Cited by 38 · see citing works
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss‐Ayali, D., Viukov, S. V., Guilliams, M., Misharin, A. V., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.008 · Cited by 37 · see citing works
PAN-INTACT enables direct isolation of lineage-specific nuclei from fibrous tissues
Bhattacharyya, S., Sathe, A. A., Bhakta, M., Xing, C., & Munshi, N. V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214677 · Cited by 18 · see citing works
A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation
Padmanabhan, A., de Soysa, Y., Pelonero, A., Sapp, V., Shah, P. P., Wang, Q., Li, L., Lee, C. Y., Sadagopan, N., Nishino, T., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00431-1 · Cited by 17 · see citing works
Self-citationPinteaux, E., Abdulaal, W. H., Mufazalov, I. A., Humphreys, N. E., Jackson, M. S., Francis, S., Müller, W., & Waisman, A. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01928-5 · Cited by 11 · see citing works
Flagged first, then by citations
2 of the 57 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Targeting immune–fibroblast cell communication in heart failure
Amrute, J. M., Luo, X., Penna, V., Yang, S., Yamawaki, T., Hayat, S., Bredemeyer, A., Jung, I.-H., Kadyrov, F. F., Heo, G. S., et al. (2024) · Nature · doi:10.1038/s41586-024-08008-5 · Cited by 298 · see citing works
Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure
Ghazal, R., Wang, M., Liu, D., Tschumperlin, D. J., & Pereira, N. L. (2025) · Circulation Research · doi:10.1161/circresaha.124.325402 · Cited by 109 · see citing works
Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis
Cho, S., Rhee, S., Madl, C. M., Caudal, A., Thomas, D., Kim, H., Kojic, A., Shin, H. S., Mahajan, A., Jahng, J. W. S., et al. (2025) · Nature · doi:10.1038/s41586-025-08945-9 · Cited by 72 · see citing works
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63 · see citing works
Immunometabolism in heart failure
Andreadou, I., Ghigo, A., Nikolaou, P., Świrski, F. K., Thackeray, J. T., Heusch, G., & Vilahur, G. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01165-8 · Cited by 69 · see citing works
Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis
Li, Z., Rigau, A. R., Xie, W., Huang, L., Ye, W., Li, Y., Matei, A., Bergmann, C., Shao, X., Zou, H., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.04.025 · Cited by 42 · see citing works
Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies
Chen, X., Zhang, J., Guo, L., Wu, C., Zhou, J., Xu, M., Mo, L., Li, Y., & He, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02532-0 · Cited by 37 · see citing works
Comprehensive transcription factor perturbations recapitulate fibroblast transcriptional states
Southard, K. M., Ardy, R. C., Tang, A., O'Sullivan, D., Metzner, E., Guruvayurappan, K., & Norman, T. M. (2025) · Nature Genetics · doi:10.1038/s41588-025-02284-1 · Cited by 42 · see citing works
Moreno-Loaiza, O., Soares, V. C., Souza, M. D. A., Vera, N., Guirao, A. R. D. Y., da Silva, T. P., Pozes, A. B., Perticarrari, L., Monteiro, E., Albino, M. C., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00610-8 · Cited by 24 · see citing works
Cardiac fibrosis: from mechanisms and models to medicines
Liu, W., Wu, X., Zeng, W., Chandy, M., & Wu, J. C. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.07.016 · Cited by 23 · see citing works
Crosstalk between macrophages and adjacent cells in AKI to CKD transition
Lin, Y., Yang, Q., & Zeng, R. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2478482 · Cited by 18 · see citing works
Li, L., Liao, J., Zhang, Y., Yao, Z., Huang, J., Wu, K., Lu, L., Peng, Y., Zhu, H., Hong, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202503691 · Cited by 16 · see citing works
Self-citationTargeting macrophage–fibroblast interactions in the failing heart
Frangogiannis, N. G. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01112-z · Cited by 14 · see citing works
Schuetze, K. B., Stratton, M. S., Bagchi, R. A., Hobby, A. R. H., Felisbino, M. B., Rubino, M., Toni, L. S., Reges, C. R., Cavasin, M. A., McMahan, R. H., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00438.2024 · Cited by 13 · see citing works
Self-citationTian, H., Xiong, Y., Zhan, J., Lu, Z., Zhang, Y., Leng, Y., Huang, Q., & Xia, Z. (2025) · Advanced Science · doi:10.1002/advs.202509952 · Cited by 14 · see citing works
Cell type specificity of Hippo-YAP signaling in cardiac development and disease
Guan, J., & Re, D. P. D. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.08.003 · Cited by 12 · see citing works
Kallikourdis, M., Cochran, J. D., Walsh, K. X., & Condorelli, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325489 · Cited by 12 · see citing works
Structural immunity: immune cells as architects of tissue barriers
Özcan, A., Vicanolo, T., Angeli, V., Rinkevich, Y., & Hidalgo, A. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01230-w · Cited by 10 · see citing works
Aguado‐Alvaro, L. P., Garitano, N., Esser‐Skala, W., Sayers, J. R., del Valle, C., Alameda, D., Mendieta-Esteban, J., Calleja-Cervantes, M. E., Goñi‐Salaverri, A., Zazpe, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66597-9 · Cited by 13 · see citing works
Spatiotemporal Proliferative Heterogeneity of Intraorgan Endothelial Cells
Han, M., Liu, Z., Liu, L., Kang, Z., Huang, X., Smart, N., Li, X., Shu, Q., & Zhou, B. (2025) · Circulation Research · doi:10.1161/circresaha.125.326748 · Cited by 8 · see citing works
The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Psarras, S. (2024) · Biomolecules · doi:10.3390/biom14111403 · Cited by 8 · see citing works
Papachristoforou, E., Kong, K., Colella, F., Tam, J., Luft, J., Sutherland, E. F., Veizades, S. A., Grzelka, M., Qui, P. K., Asif, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.27.671899 · Cited by 7 · see citing works
Fibroblasts as key cellular targets in acupuncture therapy: a mechanistic perspective
Tu, S.-W., Kawanokuchi, J., Takagi, K., Liu, Y., Li, Y.-W., Li, J., Tu, J., Ma, N., & Guo, Y. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1662525 · Cited by 9 · see citing works
Leveraging Single-Cell Technologies to Advance Understanding of Myocardial Disease
Gardner, R. S., Tucker, N. R., & Amancherla, K. V. (2026) · Circulation Research · doi:10.1161/circresaha.125.326002 · Cited by 8 · see citing works
Wells, C., Nguyen, D. C., Brainard, R. E., McNally, L. A., Silva, M. D., Brittian, K. R., Garrett, L. T., Taylor, M., Martinez‐Ondaro, Y., Howard, C., et al. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.07.005 · Cited by 7 · see citing works
Gu, Y., Zhu, W., Zhang, Z., Shu, H., Huang, H., & Sun, X. S. (2025) · Genes · doi:10.3390/genes16070817 · Cited by 6 · see citing works
Ferroptosis in Myocardial Fibrosis: Mechanisms and Therapeutic Insights
Lin, X., Li, W., Ye, J., & Li, L. (2026) · Antioxidants · doi:10.3390/antiox15010070 · Cited by 8 · see citing works
Self-citationXiao, H., Zhang, W., Liu, J., Ma, Y., Liu, D., Li, M., Xin, R., He, L., & Liu, S. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503560 · Cited by 6 · see citing works
Macrophage heterogeneity and plasticity: mechanism and therapeutics
Li, S., Yang, Y., Qiu, H., & Pang, L. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.02.002 · Cited by 10 · see citing works
Beneficial Effects of Different Types of Exercise on Diabetic Cardiomyopathy
Ma, X., Gao, H., Wang, Z., Zhu, D., Dai, W., Wu, M., Guo, Y., Zhao, L., & Xiao, W. (2025) · Biomolecules · doi:10.3390/biom15091223 · Cited by 9 · see citing works
Zhu, D., Li, J., Yu, B., Liu, N., Guo, X. M., Su, Y., Wang, Y., Huang, Y., Liang, L., Hou, L., et al. (2026) · Burns & Trauma · doi:10.1093/burnst/tkag002 · Cited by 6 · see citing works
Self-citationJiao, X., Lai, L., Qian, Y., Sun, B., & Yang, W. (2025) · The International Journal of Biological Markers · doi:10.1177/03936155251335975 · Cited by 5 · see citing works
Hunter, C. R., & Hudson, J. E. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02246-3 · Cited by 5 · see citing works
Youness, M., Ekhteraei‐Tousi, S., Nagaraju, C. K., Puertas, R. D., Thienpont, B., Rega, F., Sipido, K. R., & Roderick, H. L. (2025) · Genome Medicine · doi:10.1186/s13073-025-01580-z · Cited by 7 · see citing works
Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets
Liu, X., Wang, Z., Zhu, H., Han, Y., & Ji, Q. (2026) · MedComm · doi:10.1002/mco2.70605 · Cited by 5 · see citing works
The feasibility of targeting macrophage for disease treatment: roles of CEBPD
Fan, T., Lin, S., Zhou, J., Chen, J., & Wang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650161 · Cited by 6 · see citing works
Immune Cell Dynamics in Heart Failure: Implicated Mechanisms and Therapeutic Targets
Li, G., He, W., & Wang, D. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15238 · Cited by 4 · see citing works
Inflammatory mechanisms and targeted drugs in heart failure
Han, H., Xu, J., Zhou, Z., Zhong, C., Li, H., Liu, A., & Cui, J. (2025) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2025.2608225 · Cited by 6 · see citing works
Septin4 Regulates Cardiac Fibrosis After Pressure Overload
Yücel, D., de Araújo, N. F., Souza-Neto, F., Smith, C., Lin, W., Torniainen, A. A., Hall, M. L., Townsend, D., Ogle, B. M., & van Berlo, J. H. (2025) · Circulation Research · doi:10.1161/circresaha.125.326758 · Cited by 4 · see citing works
Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango
Kumar, V., & Bansal, S. S. (2025) · Biomolecules · doi:10.3390/biom15010058 · Cited by 5 · see citing works
Wang, Y., Fan, M., Chen, L., Gill, P. S., Wang, X., Ha, T., Williams, D. L., Li, C., & Yang, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1587898 · Cited by 4 · see citing works
Qiu, Z., Zhang, Q., Li, X., & Xie, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08046-9 · Cited by 4 · see citing works
Kozdrowicki, M., Szczepaniak, P., Kyslyi, V. F., Carnevale, L., Carnevale, D., Lembo, G., Guzik, T. J., & Mikolajczyk, T. P. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag054 · Cited by 4 · see citing works
Cardiac epigenome in heart development and disease
Laurette, P., & Gilsbach, R. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01223-1 · Cited by 4 · see citing works
Jiao, X., Lai, L., Bo, S., Qian, Y., & Yang, W. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114513 · Cited by 4 · see citing works
Bi, T., Chen, L., Wang, T., Miao, W., Zhai, S., Huang, R., Sun, Q., Chen, Y., Su, H., Zhou, J., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04036-7 · Cited by 4 · see citing works
Zhang, D., Zhang, Y.-H., Liu, B., Yang, H., Li, G., Zhou, H., Wang, Y., & Xu, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168066 · Cited by 4 · see citing works
Interconnected Pathways and Therapeutic Implications for Cardiovascular Aging and Diseases
Bai, X., Zhang, Y., Qu, J. T., & Liu, G. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.10.017 · Cited by 3 · see citing works
Immunological control of skin development: from homeostasis to developmental pathologies
Wei, Y., Gu, J., Zhao, Z., & Gu, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1685633 · Cited by 4 · see citing works
Shia, Y. X., Pappritz, K., Kaltenbach, A. C., Guo, L., Fardella, V., Linthout, S. V., Carnevale, D., Steffens, S., & Puhl, S. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01116-x · Cited by 3 · see citing works
Shokravi, A., Luo, Y., & Rabkin, S. W. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168103 · Cited by 2 · see citing works
The Spectrum of Fibroblast Immune Biology
Guarnieri, A., & Turley, S. J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083024-035801 · Cited by 3 · see citing works
Wilson, T. D., Philips, E. A., Alharithi, Y. J., Broberg, C., Vanderpool, J., Rakshe, S. K., Fei, S. S., Davis, B. A., Koch, S. E., Zhu, Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.15.648971 · Cited by 2 · see citing works
Delacroix, C., Ali, A. A., Alayrac, P., Gandon-Renard, M., Zemzem, A. B., Jouve, C., Hamidou, F., Aubert, M., Sassoon, D. A., Silvestre, J., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117393 · Cited by 2 · see citing works
(2025) · doi:10.1002/advs.202508995 · Cited by 2 · see citing works
Self-citationPerturb-seq uncovers pathological obstacles to direct cardiac reprogramming in vivo
Cai, Y., Yang, Y., Yang, J., Ding, R., Zhang, Q., Dang, X., Li, C., & Zhao, Y. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.03.006 · Cited by 2 · see citing works
Single-cell multiomics and chromatin structure reveal gene-regulatory dynamics in heart failure
Xie, Y., Tucciarone, L., Farah, E. N., Chang, L., Yang, Q., Shankar, T. S., Elison, W. S., Tran, S., Djulamsah, J., Lie, A., et al. (2026) · Science · doi:10.1126/science.ady6893 · Cited by 3 · see citing works
Soluble ST2 drives fulminant myocarditis progression via the IGF2R–YY1 mitochondrial axis
Zhuang, Y., Zhang, Z., Li, H., Abuduwufuer, K., Zhang, D., Wen, Z., Rao, X., Chen, C., Fleming, I., & Wang, D. W. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag105 · Cited by 5 · see citing works
Reid, J. D., Foster, S. R., Lor, M., Hauser, A. S., Griffen, B., Fitzsimmons, R. L., & Hudson, J. E. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.07.004 · Cited by 3 · see citing works
Cardiac fibroblast heterogeneity in cardiac fibrosis implication for cell-type-specific treatment
Gu, K., Song, D., & Chen, J. H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1740147 · Cited by 3 · see citing works
Scaffold Proteins in Fibrotic Diseases of Visceral Organs
Sun, P., Yang, L., Yu, K., Wang, J., & Chao, J. (2025) · Biomolecules · doi:10.3390/biom15030420 · Cited by 2 · see citing works
Advances in cardiac cell interaction studies: Implications for heart disease treatment
Huang, L., Xie, B., Xiang, A. P., & Xiang, Q. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112161 · Cited by 3 · see citing works
Myeloid‐Mesenchymal Crosstalk in Lung Fibrosis
Bhattacharyya, A., Yadav, P., & Bhattacharya, M. (2025) · Comprehensive physiology · doi:10.1002/cph4.70004 · Cited by 2 · see citing works
Sun, X., Sigal, S., Cosma, M.-A., Villiers, C. D., Weinberger, M., & Riley, P. R. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00430-1 · Cited by 5 · see citing works
Garlanda, C., Ceglie, I. D., & Jaillon, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00178-2 · Cited by 1 · see citing works
RNA Therapeutics for In Vivo CAR-Macrophage: Advancing Cardiac Immunotherapy
Ben‐Aicha, S., Shmool, T. A., & Emanueli, C. (2025) · Circulation Research · doi:10.1161/circresaha.125.327128 · Cited by 1 · see citing works
Wang, S., Wu, T., Dai, J., Liu, X., He, L., Dong, Y., Zhao, L., & Li, N. (2025) · Toxics · doi:10.3390/toxics14010052 · Cited by 1 · see citing works
Nguyen, D. C., Stephan, J., Luque, L. G., Brainard, R. E., Brittian, K. R., Wells, C., Teer, M. S., Martinez‐Ondaro, Y., Gouwens, K. R., Little, D. T., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73646-4 · Cited by 3 · see citing works
Targeting RUNX1 in Macrophages Facilitates Cardiac RecoveryPreprint
Amrute, J., Zhu, A., Pai, Y.-L., Hector-Greene, M., An, Y., Kim, K. R., Sheth, M. U., Padmanabhan, A., Lee, C. Y., Yamawaki, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.665779 · Cited by 2 · see citing works
Self-citationZheng, H., Liang, Y., & Tian, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04652-3 · Cited by 1 · see citing works
Mapping spatially-resolved transcriptomes in systemic sclerosisPreprint
Li, Z., Rigau, A. R., Xie, W., Huang, L., Shao, X., Li, Y., Matei, A.-E., Ye, W., Zou, H., Pinello, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.14.632962 · Cited by 2 · see citing works
Cx3cr1 depletion ameliorates lipid metabolic dysregulation and pulmonary fibrosis induced by silica
Hu, E., Wang, Y., Li, Z., Zhang, J., Huang, W., Shen, J., Liu, D., Zhu, Z., Tian, L., & Wang, Y. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.111999 · Cited by 1 · see citing works
Precision cardiology: Integrating gene therapy, genome editing, and single-cell genomics
Nishino, T., & Ono, K. (2025) · Journal of Cardiology · doi:10.1016/j.jjcc.2025.09.009 · Cited by 1 · see citing works
Self-citationZhang, J. M., Wang, Y., Huo, C., Jiao, X., Zeng, X., Li, J., Zhu, Z., Wang, Y., Tian, L., & Wang, Y. (2026) · Toxicology · doi:10.1016/j.tox.2026.154476 · Cited by 1 · see citing works
Toll-like receptor 7 constrains efferocytosis in myocardial injury
Lai, Y., Chong, S. Y., Nair, V., Cui, W., Li, L., Liu, S., Zhao, X., Yang, L., Hou, X., Zharkova, O., et al. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01185-6 · Cited by 1 · see citing works
Self-citationImmunometabolic Remodeling in Ischemic and Non-Ischemic Heart Failure
Zang, X., Zhang, G., Kong, S., Zhao, C., Sun, X., & Zhang, K. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10800-9 · Cited by 1 · see citing works
Zhang, K., Fan, Y., & Wang, Y. (2026) · Journal of International Medical Research · doi:10.1177/03000605261465295 · Cited by 1 · see citing works
Gong, J., Morgan, H., Little, K., Cook, C., Dutta, S., Bhullar, R., Lim, O., Taylor, T., Arora, R., Raja, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.08.743525
BRD4: From molecular understanding to therapeutics development
Wu, S.-Y., & Chiang, C. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.07.004 · Cited by 2 · see citing works
Wu, Z., Luo, B., Kong, D., Liu, H., Xie, W., Hu, C., He, J., Cao, D., Xi, R., Shen, Z., et al. (2026) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2026.03.593 · Cited by 1 · see citing works
Philips, E. A., Alharithi, Y. J., Wilson, T. D., Broberg, C., Davis, B. A., Koch, S. E., Carbone, L., Rubinstein, J. H., Gurley, S. B., Kumar, S., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5228904
The regulatory logic linking inflammation and fibrosis
Alexanian, M., & Srivastava, D. (2026) · Cell · doi:10.1016/j.cell.2026.08.001 · Cited by 2 · see citing works
Self-citationZhuo, C., Chen, L., Sun, X., Chen, T., Cai, H., & Hu, X. (2026) · Global Heart · doi:10.5334/gh.1526
Yimeng, L. I. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-02001-z
Enhancer Dynamics for Gene Regulation in the Cardiovascular System
Wang, Z., & Gan, P. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323110
Single-Cell and Spatial Transcriptomics in Renal Injury and Fibrosis Research
Chen, Y., Ye, Z., & Wang, W. (2026) · Kidney Diseases · doi:10.1159/000552224
Gong, W., Wu, Z., Luo, B., Kong, D., Miao, X., Liu, H., Xie, W., Hu, C., He, J., Cao, D., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5850890/v1
- Authors
- Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Pelonero, A., Lee, C. Y., Sadagopan, N., Huang, Y., Auclair, K., Zhu, A., An, Y., Ekstrand, C. A., Martinez, C., Teran, B. G., Flanigan, W. R., Kim, C. K.-S., Lumbao-Conradson, K., Gardner, Z., Li, L., Costa, M. W., Jain, R., Charo, I., Combes, A. J., Haldar, S. M., Pollard, K. S., Vagnozzi, R. J., McKinsey, T. A., Przytycki, P. F., & Srivastava, D.
- Affiliations
- Gladstone Institutes (US)
- University of Colorado Anschutz (US)
- University of California, San Francisco (US)
- University of Pennsylvania (US)
- Amgen (United States) (US)
- Boston University (US)
- Corresponding author
- Alexanian, Michael
- ORCID
- Alexanian, Michael
- Padmanabhan, Arun
- Nishino, Tomohiro
- Travers, Joshua G.
- Ye, Lin
- Pelonero, Angelo
- Lee, Clara Youngna
- Huang, Yu
- An, Yuqian
- Ekstrand, Christina A.
- Martinez, Cassandra
- Flanigan, Will R.
- Kim, Charis Kee-Seon
- Lumbao-Conradson, Koya
- Gardner, Zachary
- Li, Li
- Costa, Mauro W.
- Jain, Rajan
- Combes, Alexis J.
- Haldar, Saptarsi M.
- Pollard, Katherine S.
- Vagnozzi, Ronald J.
- McKinsey, Timothy A.
- Przytycki, Pawel F.
- Srivastava, Deepak
- Venue
- Nature
- Published
- 2024-10-23
- Volume
- 635
- Issue
- 8038
- Pages
- 434-443
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC11698514
- OpenAlex
- W4403680473
- Semantic Scholar
- 4068b221dac01063659a124623f00bb7bc087cc7
- Cited by
- 140
- References
- 57
- Citations by year
- 2026: 69 · 2025: 64 · 2024: 7
- FWCI
- 41.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Science Foundation
- American Heart Association
- A.P. Giannini Foundation
- Tobacco-Related Disease Research Program
- Giannini Foundation of Agricultural Economics
- Frank A. Campini Foundation
- Sarnoff Cardiovascular Research Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (186704)
- Italfarmaco
- National Institutes of Health
- Agency for Healthcare Research and Quality (R01HS015100)
- Japan Society for the Promotion of Science
- National Heart, Lung, and Blood Institute (R01HL147558, K99HL166708, R01HL116848, P01HL146366, R01HL150100, P01HL089707, R01HL127240, U01HL098179, R01HL150225, R01HL057181, K08HL157700, R01HL169578, R35HL166663)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119594)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- heart failure, myocardial fibrosis, BRD4, chromatin remodeling, macrophages, CX3CR1+ macrophages, fibroblast activation, IL-1β, MEOX1, RelA/p65, chromatin accessibility, chronic inflammation, tissue remodeling
- MeSH terms
- CX3C Chemokine Receptor 1, Bromodomain Containing Proteins, Animals, Cell Communication, Chromatin, Enhancer Elements, Genetic, Female, Fibroblasts, Fibrosis, Heart Failure, Humans, Macrophages, Male, Mice, Inbred C57BL, Nuclear Proteins, Transcription Factors, Homeodomain Proteins, Cell Cycle Proteins, Chromatin Assembly and Disassembly, Mice, Transcription Factor RelA, Interleukin-1beta, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review